IBDEI11D ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16842,0)
 ;;=A69.29^^61^777^20
 ;;^UTILITY(U,$J,358.3,16842,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16842,1,3,0)
 ;;=3^Conditions d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,16842,1,4,0)
 ;;=4^A69.29
 ;;^UTILITY(U,$J,358.3,16842,2)
 ;;=^5000379
 ;;^UTILITY(U,$J,358.3,16843,0)
 ;;=A69.23^^61^777^5
 ;;^UTILITY(U,$J,358.3,16843,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16843,1,3,0)
 ;;=3^Arthritis d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,16843,1,4,0)
 ;;=4^A69.23
 ;;^UTILITY(U,$J,358.3,16843,2)
 ;;=^5000378
 ;;^UTILITY(U,$J,358.3,16844,0)
 ;;=A51.0^^61^777^32
 ;;^UTILITY(U,$J,358.3,16844,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16844,1,3,0)
 ;;=3^Genital Syphilis,Primary
 ;;^UTILITY(U,$J,358.3,16844,1,4,0)
 ;;=4^A51.0
 ;;^UTILITY(U,$J,358.3,16844,2)
 ;;=^5000272
 ;;^UTILITY(U,$J,358.3,16845,0)
 ;;=A52.3^^61^777^57
 ;;^UTILITY(U,$J,358.3,16845,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16845,1,3,0)
 ;;=3^Neurosyphilis,Unspec
 ;;^UTILITY(U,$J,358.3,16845,1,4,0)
 ;;=4^A52.3
 ;;^UTILITY(U,$J,358.3,16845,2)
 ;;=^5000298
 ;;^UTILITY(U,$J,358.3,16846,0)
 ;;=A52.10^^61^777^56
 ;;^UTILITY(U,$J,358.3,16846,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16846,1,3,0)
 ;;=3^Neurosyphilis Symptomatic,Unspec
 ;;^UTILITY(U,$J,358.3,16846,1,4,0)
 ;;=4^A52.10
 ;;^UTILITY(U,$J,358.3,16846,2)
 ;;=^5000291
 ;;^UTILITY(U,$J,358.3,16847,0)
 ;;=A52.9^^61^777^52
 ;;^UTILITY(U,$J,358.3,16847,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16847,1,3,0)
 ;;=3^Late Syphilis,Unspec
 ;;^UTILITY(U,$J,358.3,16847,1,4,0)
 ;;=4^A52.9
 ;;^UTILITY(U,$J,358.3,16847,2)
 ;;=^5000308
 ;;^UTILITY(U,$J,358.3,16848,0)
 ;;=A53.9^^61^777^84
 ;;^UTILITY(U,$J,358.3,16848,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16848,1,3,0)
 ;;=3^Syphilis,Unspec
 ;;^UTILITY(U,$J,358.3,16848,1,4,0)
 ;;=4^A53.9
 ;;^UTILITY(U,$J,358.3,16848,2)
 ;;=^5000310
 ;;^UTILITY(U,$J,358.3,16849,0)
 ;;=B37.3^^61^777^19
 ;;^UTILITY(U,$J,358.3,16849,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16849,1,3,0)
 ;;=3^Candidiasis Vulva/Vagina
 ;;^UTILITY(U,$J,358.3,16849,1,4,0)
 ;;=4^B37.3
 ;;^UTILITY(U,$J,358.3,16849,2)
 ;;=^5000615
 ;;^UTILITY(U,$J,358.3,16850,0)
 ;;=B58.9^^61^777^89
 ;;^UTILITY(U,$J,358.3,16850,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16850,1,3,0)
 ;;=3^Toxoplasmosis,Unspec
 ;;^UTILITY(U,$J,358.3,16850,1,4,0)
 ;;=4^B58.9
 ;;^UTILITY(U,$J,358.3,16850,2)
 ;;=^5000733
 ;;^UTILITY(U,$J,358.3,16851,0)
 ;;=A59.01^^61^777^90
 ;;^UTILITY(U,$J,358.3,16851,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16851,1,3,0)
 ;;=3^Trichomonal Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,16851,1,4,0)
 ;;=4^A59.01
 ;;^UTILITY(U,$J,358.3,16851,2)
 ;;=^121763
 ;;^UTILITY(U,$J,358.3,16852,0)
 ;;=B59.^^61^777^70
 ;;^UTILITY(U,$J,358.3,16852,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16852,1,3,0)
 ;;=3^Pneumocystosis
 ;;^UTILITY(U,$J,358.3,16852,1,4,0)
 ;;=4^B59.
 ;;^UTILITY(U,$J,358.3,16852,2)
 ;;=^5000734
 ;;^UTILITY(U,$J,358.3,16853,0)
 ;;=H83.09^^61^777^51
 ;;^UTILITY(U,$J,358.3,16853,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16853,1,3,0)
 ;;=3^Labyrinthitis,Unspec Ear
 ;;^UTILITY(U,$J,358.3,16853,1,4,0)
 ;;=4^H83.09
 ;;^UTILITY(U,$J,358.3,16853,2)
 ;;=^5006897
 ;;^UTILITY(U,$J,358.3,16854,0)
 ;;=H83.01^^61^777^50
 ;;^UTILITY(U,$J,358.3,16854,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16854,1,3,0)
 ;;=3^Labyrinthitis,Right Ear
 ;;^UTILITY(U,$J,358.3,16854,1,4,0)
 ;;=4^H83.01
